4//SEC Filing
VANLENT ANNE 4
Accession 0001062993-22-023029
CIK 0001273636other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 9:23 AM ET
Size
18.0 KB
Accession
0001062993-22-023029
Insider Transaction Report
Form 4
VANLENT ANNE
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−10,000→ 0 totalExercise: $4.25Exp: 2028-07-25→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−12,000→ 0 totalExercise: $4.72Exp: 2030-12-16→ Common Stock (12,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−16,000→ 0 totalExercise: $15.13Exp: 2026-08-17→ Common Stock (16,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−8,000→ 0 totalExercise: $7.75Exp: 2027-02-28→ Common Stock (8,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−10,000→ 0 totalExercise: $6.90Exp: 2028-11-15→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−10,000→ 0 totalExercise: $3.02Exp: 2029-12-04→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−14,000→ 0 totalExercise: $2.17Exp: 2031-11-30→ Common Stock (14,000 underlying)
Footnotes (1)
- [F1]At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option.
Issuer
APPLIED GENETIC TECHNOLOGIES CORP
CIK 0001273636
Entity typeother
Related Parties
1- filerCIK 0001229243
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 9:23 AM ET
- Size
- 18.0 KB